# INVOKANA

NDC: 55154-1426
Generic name: canagliflozin
Labeler / Manufacturer: Cardinal Health 107, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130329

FDA application: NDA204042

## Active ingredients

- CANAGLIFLOZIN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55154-1426"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55154-1426
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f76e16f-0c24-454a-81af-4080b312c940